Metraipolis › archive › dc_c65cd2fcb854

Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications — Europe PMC PMID:41881983

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41881983
DOI
10.1038/s41392-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-11-04T07:30:29.458Z
SHA-256 of the archived text
3ea1d18a978993481ad6995393b6a6e62b564e18894c508d70c59c6a977e096a
Stable URL of this page
https://metraipolis.com/documento/dc_c65cd2fcb854

How to cite

Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications — Europe PMC PMID:41881983 — Europe PMC (en), https://europepmc.org/article/MED/41881983 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c65cd2fcb854 (Metraipolis archive dc_c65cd2fcb854, sha256 3ea1d18a978993481ad6995393b6a6e62b564e18894c508d70c59c6a977e096a)
BibTeX
@misc{dcc65cd2fcb854,
  title = {Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications — Europe PMC PMID:41881983},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41881983},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c65cd2fcb854; sha256 3ea1d18a978993481ad6995393b6a6e62b564e18894c508d70c59c6a977e096a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41881983. Agents can read the archived copy with the MCP tool read_document.